Filing Details

Accession Number:
0001305773-18-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-30 21:22:37
Reporting Period:
2018-04-26
Accepted Time:
2018-04-30 21:22:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305773 Conformis Inc CFMS Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645522 Philipp Lang C/O Conformis, Inc.
600 Technology Park Drive
Billerica MA 01821
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-26 13,900 $1.51 576,475 No 4 S Direct
Common Stock Disposition 2018-04-26 13,686 $1.51 683,267 No 4 S Indirect See footnote.
Common Stock Disposition 2018-04-26 12,498 $1.50 0 No 4 S Indirect See footnote.
Common Stock Disposition 2018-04-27 70,566 $1.47 505,909 No 4 S Direct
Common Stock Disposition 2018-04-27 70,736 $1.47 612,531 No 4 S Indirect See footnote.
Common Stock Disposition 2018-04-30 235,592 $1.34 270,317 No 4 S Direct
Common Stock Disposition 2018-04-30 234,234 $1.34 378,297 No 4 S Indirect See footnote.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Direct
No 4 S Indirect See footnote.
No 4 S Direct
No 4 S Indirect See footnote.
Footnotes
  1. This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  2. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.47-$1.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The shares are held directly by the NP Irrevocable Trust udt dated 12/28/12. The Reporting Person's immediate family members are beneficiaries of the NP Irrevocable Trust udt dated 12/28/12, and the Reporting Person disclaims beneficial ownership of all shares except to the extent of his pecuniary interest therein.
  4. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.47-$1.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. The shares are held directly by the Reporting Person's children.
  6. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.44-$1.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.29-$1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  8. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.29-$1.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.